TY  - GEN
AU  - Forns,Xavier
AU  - Lee,Samuel S
AU  - Valdes,Joaquin
AU  - Lens,Sabela
AU  - Ghalib,Reem
AU  - Aguilar,Humberto
AU  - Felizarta,Franco
AU  - Hassanein,Tarek
AU  - Hinrichsen,Holger
AU  - Rincon,Diego
AU  - Morillas,Rosa
AU  - Zeuzem,Stefan
AU  - Horsmans,Yves
AU  - Nelson,David R
AU  - Yu,Yao
AU  - Krishnan,Preethi
AU  - Lin,Chih-Wei
AU  - Kort,Jens J
AU  - Mensa,Federico J
TI  - Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial
SN  - 1474-4457
PY  - 2017///1002
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Aminoisobutyric Acids
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Benzimidazoles
KW  - Cyclopropanes
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - classification
KW  - Hepatitis C
KW  - drug therapy
KW  - Humans
KW  - Lactams, Macrocyclic
KW  - Leucine
KW  - analogs & derivatives
KW  - Liver Cirrhosis
KW  - complications
KW  - Male
KW  - Middle Aged
KW  - Proline
KW  - Pyrrolidines
KW  - Quinoxalines
KW  - Sulfonamides
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study
UR  - https://doi.org/10.1016/S1473-3099(17)30496-6
ER  -